APEX | The Current State of Play on MFN: Skepticism on Administrative Execution, Attention Around Congressional Action
Shares:
Congrats to patient advocate/CEO John Crowley, who will be taking over as the CEO of the Biotechnology Innovation Organization. No one knows the stakes of drug development better than John,
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
I thought Cost Curve would be off today, but there’s just too much popping to leave it to Monday. So let’s touch some bases before we all go into our